标题
Gastric adenocarcinoma
作者
关键词
-
出版物
Nature Reviews Disease Primers
Volume 3, Issue -, Pages 17036
出版商
Springer Nature
发表日期
2017-06-01
DOI
10.1038/nrdp.2017.36
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- It Is Time to Stop Using Epirubicin to Treat Any Patient With Gastroesophageal Adenocarcinoma
- (2017) Elena Elimova et al. JOURNAL OF CLINICAL ONCOLOGY
- HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology
- (2017) Angela N. Bartley et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab (ONO-4538/BMS-936558) as salvage treatment after second or later-line chemotherapy for advanced gastric or gastro-esophageal junction cancer (AGC): A double-blinded, randomized, phase III trial.
- (2017) Yoon-Koo Kang et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study
- (2017) Peter C Thuss-Patience et al. LANCET ONCOLOGY
- 1058PDA PHASE I MULTI-ARM DOSE-EXPANSION STUDY OF THE ANTI-PROGRAMMED CELL DEATH-LIGAND-1 (PD-L1) ANTIBODY MEDI4736: PRELIMINARY DATA
- (2017) N.H. Segal et al. ANNALS OF ONCOLOGY
- Randomized phase II study of nimotuzumab, an anti-EGFR antibody, plus irinotecan in patients with 5-fluorouracil–based regimen-refractory advanced or recurrent gastric cancer in Korea and Japan: Preliminary results.
- (2017) Y. H. Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma
- (2016) S.-E. Al-Batran et al. ANNALS OF ONCOLOGY
- Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) E. C. Smyth et al. ANNALS OF ONCOLOGY
- Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer
- (2016) M. Chatterjee et al. ANNALS OF ONCOLOGY
- Long-term Quality of Life After Distal Subtotal and Total Gastrectomy
- (2016) Seung Soo Lee et al. ANNALS OF SURGERY
- Decreased Morbidity of Laparoscopic Distal Gastrectomy Compared With Open Distal Gastrectomy for Stage I Gastric Cancer
- (2016) Wook Kim et al. ANNALS OF SURGERY
- Long-Term Survival in Patients with Postoperative Intra-Abdominal Infectious Complications After Curative Gastrectomy for Gastric Cancer: A Propensity Score Matching Analysis
- (2016) Keiichi Fujiya et al. ANNALS OF SURGICAL ONCOLOGY
- Yield of Staging Laparoscopy and Lavage Cytology for Radiologically Occult Peritoneal Carcinomatosis of Gastric Cancer
- (2016) Naruhiko Ikoma et al. ANNALS OF SURGICAL ONCOLOGY
- Mechanisms for the induction of gastric cancer by Helicobacter pylori infection: aberrant DNA methylation pathway
- (2016) Masahiro Maeda et al. Gastric Cancer
- Chronicles of a cancer foretold: 35 years of gastric cancer risk assessment
- (2016) Massimo Rugge et al. GUT
- Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report
- (2016) P Malfertheiner et al. GUT
- Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma
- (2016) Elizabeth D Thompson et al. GUT
- Immune checkpoint blockade in human cancer therapy: lung cancer and hematologic malignancies
- (2016) Murali Janakiram et al. Immunotherapy
- MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia
- (2016) Simone S. Riedel et al. JOURNAL OF CLINICAL INVESTIGATION
- Multicenter double-blind randomized phase II: FOLFOX + ziv-aflibercept/placebo for patients (pts) with chemo-naive metastatic esophagogastric adenocarcinoma (MEGA).
- (2016) Peter C. Enzinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Lapatinib in Gastric Cancer: What Is the LOGiCal Next Step?
- (2016) Yelena Y. Janjigian JOURNAL OF CLINICAL ONCOLOGY
- A randomized, open-label, multicenter, adaptive phase 2/3 study of trastuzumab emtansine (T-DM1) versus a taxane (TAX) in patients (pts) with previously treated HER2-positive locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma (LA/MGC/GEJC).
- (2016) Yoon-Koo Kang et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II study of AZD4547 in FGFR amplified tumours: Gastroesophageal cancer (GC) cohort pharmacodynamic and biomarker results.
- (2016) Elizabeth Catherine Smyth et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
- (2016) Jin Li et al. JOURNAL OF CLINICAL ONCOLOGY
- FAST: An international, multicenter, randomized, phase II trial of epirubicin, oxaliplatin, and capecitabine (EOX) with or without IMAB362, a first-in-class anti-CLDN18.2 antibody, as first-line therapy in patients with advanced CLDN18.2+ gastric and gastroesophageal junction (GEJ) adenocarcinoma.
- (2016) Salah-Eddin Al-Batran et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety, PD-L1 expression, and clinical activity of avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with advanced gastric or gastroesophageal junction cancer.
- (2016) Hyun Cheol Chung et al. JOURNAL OF CLINICAL ONCOLOGY
- Updated results for the advanced esophageal carcinoma cohort of the phase Ib KEYNOTE-028 study of pembrolizumab (MK-3475).
- (2016) Toshihiko Doi et al. JOURNAL OF CLINICAL ONCOLOGY
- Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial
- (2016) Nick Pavlakis et al. JOURNAL OF CLINICAL ONCOLOGY
- Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial
- (2016) Yanfeng Hu et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors
- (2016) Aditya Bagrodia et al. JOURNAL OF CLINICAL ONCOLOGY
- Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC—A Randomized Phase III Trial
- (2016) J. Randolph Hecht et al. JOURNAL OF CLINICAL ONCOLOGY
- Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology
- (2016) Jaffer A. Ajani et al. Journal of the National Comprehensive Cancer Network
- Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
- (2016) Kei Muro et al. LANCET ONCOLOGY
- Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial
- (2016) Kazumasa Fujitani et al. LANCET ONCOLOGY
- HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of Lapatinib
- (2016) Michael F. Press et al. MOLECULAR CANCER THERAPEUTICS
- Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression
- (2016) Hanane Laklai et al. NATURE MEDICINE
- PD-1 says goodbye, TIM-3 says hello
- (2016) Diana Romero Nature Reviews Clinical Oncology
- Pathogenic enablers — toxic relationships in the stomach
- (2016) Lydia E. Wroblewski et al. Nature Reviews Gastroenterology & Hepatology
- The Proportion of Signet Ring Cell Component in Patients with Localized Gastric Adenocarcinoma Correlates with the Degree of Response to Pre-Operative Chemoradiation
- (2016) Nikolaos Charalampakis et al. ONCOLOGY
- The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas
- (2016) D. F. Quail et al. SCIENCE
- Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
- (2016) Shohei Koyama et al. Nature Communications
- The clinicopathological and prognostic significance of PD-L1 expression in gastric cancer: a meta-analysis of 10 studies with 1,901 patients
- (2016) Minghui Zhang et al. Scientific Reports
- Loss of ARID1A expression predicts poor survival prognosis in gastric cancer: a systematic meta-analysis from 14 studies
- (2016) Lin Yang et al. Scientific Reports
- Host SHP1 phosphatase antagonizes Helicobacter pylori CagA and can be downregulated by Epstein–Barr virus
- (2016) Priya Saju et al. Nature Microbiology
- Palbociclib (PD0332991)—a Selective and Potent Cyclin-Dependent Kinase Inhibitor
- (2016) Amy S. Clark et al. JAMA Oncology
- TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG)
- (2015) Trevor Leong et al. BMC CANCER
- The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression
- (2015) Chang-Ni Lin et al. BMC CANCER
- Marital status, education, and income in relation to the risk of esophageal and gastric cancer by histological type and site
- (2015) Jesper Lagergren et al. CANCER
- Phase 2 study of MK-2206, an allosteric inhibitor of AKT, as second-line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005)
- (2015) Ramesh K. Ramanathan et al. CANCER
- Global Cancer Incidence and Mortality Rates and Trends--An Update
- (2015) L. A. Torre et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Mortality reduction from gastric cancer by endoscopic and radiographic screening
- (2015) Chisato Hamashima et al. CANCER SCIENCE
- A New B7:CD28 Family Checkpoint Target for Cancer Immunotherapy: HHLA2
- (2015) Y. Xiao et al. CLINICAL CANCER RESEARCH
- Chemotherapy Resistance in Diffuse-Type Gastric Adenocarcinoma Is Mediated by RhoA Activation in Cancer Stem-Like Cells
- (2015) C. Yoon et al. CLINICAL CANCER RESEARCH
- Landscape of dietary factors associated with risk of gastric cancer: A systematic review and dose-response meta-analysis of prospective cohort studies
- (2015) Xuexian Fang et al. EUROPEAN JOURNAL OF CANCER
- Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma
- (2015) Patrick Tan et al. GASTROENTEROLOGY
- Helicobacter pylori Update: Gastric Cancer, Reliable Therapy, and Possible Benefits
- (2015) David Y. Graham GASTROENTEROLOGY
- Blockade of PD1 and TIM3 Restores Innate and Adaptive Immunity in Patients With Acute Alcoholic Hepatitis
- (2015) Lee J.L. Markwick et al. GASTROENTEROLOGY
- Global patterns of cardia and non-cardia gastric cancer incidence in 2012
- (2015) A Colquhoun et al. GUT
- Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis
- (2015) Jennifer M Yeh et al. GUT
- Kyoto global consensus report onHelicobacter pylorigastritis
- (2015) Kentaro Sugano et al. GUT
- False-negative rate for HER2 testing in 738 gastric and gastroesophageal junction cancers (GEC) from two global randomized clinical trials.
- (2015) David Cunningham et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer
- (2015) Yung-Jue Bang et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Biomarkers in Gastric Cancer
- (2015) Elena Elimova et al. Journal of the National Comprehensive Cancer Network
- Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
- (2015) Antoni Ribas et al. LANCET ONCOLOGY
- Macrophages are critical effectors of antibody therapies for cancer
- (2015) Kipp Weiskopf et al. mAbs
- YAP and the drug resistance highway
- (2015) Alona Keren-Paz et al. NATURE GENETICS
- Stromal contribution to the colorectal cancer transcriptome
- (2015) Claudio Isella et al. NATURE GENETICS
- The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
- (2015) Luping Lin et al. NATURE GENETICS
- Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
- (2015) Razvan Cristescu et al. NATURE MEDICINE
- Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor
- (2015) William D. Tap et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Survival Analysis of Patients with Interval Cancer Undergoing Gastric Cancer Screening by Endoscopy
- (2015) Chisato Hamashima et al. PLoS One
- Cancer Stem Cells: The Promise and the Potential
- (2015) Jaffer A. Ajani et al. SEMINARS IN ONCOLOGY
- Long-term outcomes after prophylactic bursectomy in patients with resectable gastric cancer: Final analysis of a multicenter randomized controlled trial
- (2015) Motohiro Hirao et al. SURGERY
- Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors
- (2015) A. Morello et al. Cancer Discovery
- The cancer COMPASS: navigating the functions of MLL complexes in cancer
- (2015) David J. Ford et al. Cancer Genetics
- Dietary Nitrates, Nitrites, and Nitrosamines Intake and the Risk of Gastric Cancer: A Meta-Analysis
- (2015) Peng Song et al. Nutrients
- Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy
- (2015) Ismael Riquelme et al. Oncotarget
- Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells
- (2015) T. Kouo et al. Cancer Immunology Research
- CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer
- (2015) Kazumichi Yoshida et al. Cancer Medicine
- Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma
- (2015) Hans A. Schlößer et al. OncoImmunology
- Hereditary Diffuse Gastric Cancer Syndrome
- (2015) Samantha Hansford et al. JAMA Oncology
- Utility of the Proximal Margin Frozen Section for Resection of Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer Collaborative
- (2014) Malcolm H. Squires et al. ANNALS OF SURGICAL ONCOLOGY
- Multicentre analysis of long-term outcome after surgical resection for gastric cancer liver metastases
- (2014) T. Kinoshita et al. BRITISH JOURNAL OF SURGERY
- Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
- (2014) Carola H. Ries et al. CANCER CELL
- Hippo Coactivator YAP1 Upregulates SOX9 and Endows Esophageal Cancer Cells with Stem-like Properties
- (2014) S. Song et al. CANCER RESEARCH
- Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein
- (2014) M. Janakiram et al. CLINICAL CANCER RESEARCH
- A Signature Predicting Poor Prognosis in Gastric and Ovarian Cancer Represents a Coordinated Macrophage and Stromal Response
- (2014) R. A. Busuttil et al. CLINICAL CANCER RESEARCH
- Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer
- (2014) Taroh Satoh et al. Gastric Cancer
- Integrative Identification of Epstein–Barr Virus–Associated Mutations and Epigenetic Alterations in Gastric Cancer
- (2014) Qiaoyi Liang et al. GASTROENTEROLOGY
- Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment ofHER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTAN—A Randomized, Phase III Study
- (2014) Taroh Satoh et al. JOURNAL OF CLINICAL ONCOLOGY
- Different roles for p16INK4a-Rb pathway and INK4a/ARF methylation between adenocarcinomas of gastric cardia and distal stomach
- (2014) Liying Xue et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study
- (2014) Timothy Iveson et al. LANCET ONCOLOGY
- Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
- (2014) Sung Hoon Noh et al. LANCET ONCOLOGY
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Next-generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity
- (2014) Daniel V.T. Catenacci Molecular Oncology
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma
- (2014) Miwako Kakiuchi et al. NATURE GENETICS
- Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer
- (2014) Kai Wang et al. NATURE GENETICS
- Quality of Life in the Trastuzumab for Gastric Cancer Trial
- (2014) Taroh Satoh et al. ONCOLOGIST
- Epigenetic dysregulation in Epstein-Barr virus-associated gastric carcinoma: Disease and treatments
- (2014) Tung On Yau WORLD JOURNAL OF GASTROENTEROLOGY
- Cytotoxic T Lymphocyte Antigen-4 Blockade Enhances Antitumor Immunity by Stimulating Melanoma-Specific T-cell Motility
- (2014) T. Pentcheva-Hoang et al. Cancer Immunology Research
- Prognostic Significance of Complications after Curative Surgery for Gastric Cancer
- (2013) Takeshi Kubota et al. ANNALS OF SURGICAL ONCOLOGY
- Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
- (2013) S. R. Daigle et al. BLOOD
- Loss of TGF- Adaptor 2SP Activates Notch Signaling and SOX9 Expression in Esophageal Adenocarcinoma
- (2013) S. Song et al. CANCER RESEARCH
- Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study
- (2013) Atsushi Ohtsu et al. JOURNAL OF CLINICAL ONCOLOGY
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
- (2013) Tom Waddell et al. LANCET ONCOLOGY
- Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
- (2013) Florian Lordick et al. LANCET ONCOLOGY
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Influence of tumour micro-environment heterogeneity on therapeutic response
- (2013) Melissa R. Junttila et al. NATURE
- Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation
- (2013) Luc G T Morris et al. NATURE GENETICS
- CSF-1R inhibition alters macrophage polarization and blocks glioma progression
- (2013) Stephanie M Pyonteck et al. NATURE MEDICINE
- Gastric cancer—molecular and clinical dimensions
- (2013) Roopma Wadhwa et al. Nature Reviews Clinical Oncology
- Circulating tumour cells and cell-free DNA as tools for managing breast cancer
- (2013) Leticia De Mattos-Arruda et al. Nature Reviews Clinical Oncology
- Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2
- (2013) S. K. Knutson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Significance and prognostic value of Gli-1 and Snail/E-cadherin expression in progressive gastric cancer
- (2013) Zhan-shan Wang et al. TUMOR BIOLOGY
- Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells
- (2012) Junhong Zhao et al. CANCER
- Comprehensive DNA methylation and extensive mutation analyses reveal an association between the CpG island methylator phenotype and oncogenic mutations in gastric cancers
- (2012) Jeong Goo Kim et al. CANCER LETTERS
- Organ Size Control by Hippo and TOR Pathways
- (2012) Karen Tumaneng et al. CURRENT BIOLOGY
- The benefit of mass eradication ofHelicobacter pyloriinfection: a community-based study of gastric cancer prevention
- (2012) Yi-Chia Lee et al. GUT
- Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer
- (2012) Yonghui Wu et al. GUT
- Recent Development of Gastric Cancer Prevention
- (2012) M. Kato et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- A Phase III Study of Laparoscopy-assisted Versus Open Distal Gastrectomy with Nodal Dissection for Clinical Stage IA/IB Gastric Cancer (JCOG0912)
- (2012) Kenichi Nakamura et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Biomarker Evaluation From the AVAGAST Randomized Phase III Trial
- (2012) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Fifteen-Year Effects of Helicobacter pylori, Garlic, and Vitamin Treatments on Gastric Cancer Incidence and Mortality
- (2012) Jun-Ling Ma et al. JNCI-Journal of the National Cancer Institute
- Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
- (2012) Catherine de Martel et al. LANCET ONCOLOGY
- YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29
- (2012) Karen Tumaneng et al. NATURE CELL BIOLOGY
- Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes
- (2012) Zhi Jiang Zang et al. NATURE GENETICS
- Methylation Subtypes and Large-Scale Epigenetic Alterations in Gastric Cancer
- (2012) H. Zouridis et al. Science Translational Medicine
- CpG island methylator phenotype andHelicobacter pyloriinfection associated with gastric cancer
- (2012) Ji-Bin Liu WORLD JOURNAL OF GASTROENTEROLOGY
- Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project
- (2011) C. A. Gonzalez et al. ANNALS OF ONCOLOGY
- Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer
- (2011) Junhong Zhao et al. CANCER
- The prevention of infection-associated cancers
- (2011) S. De Flora et al. CARCINOGENESIS
- Yes-Associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumulation Associates with Poor Prognosis
- (2011) W. Kang et al. CLINICAL CANCER RESEARCH
- Time Trends of Mortality from Gastric Cancer in Europe
- (2011) Amnon Sonnenberg DIGESTIVE DISEASES AND SCIENCES
- Divergent trends for gastric cancer incidence by anatomical subsite in US adults
- (2011) M. C. Camargo et al. GUT
- Low Prevalence of Helicobacter pylori-negative Gastric Cancer among Japanese
- (2011) Taiji Matsuo et al. HELICOBACTER
- Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial
- (2011) Jeeyun Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
- (2011) Zhihu Ding et al. NATURE
- Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
- (2011) Kai Wang et al. NATURE GENETICS
- Cancer of the Gastric Cardia is Rising in Incidence in an Asian Population and is Associated with Adverse Outcome
- (2011) Chris Deans et al. WORLD JOURNAL OF SURGERY
- Endoscopic resection of early gastric cancer treated by guideline and expanded National Cancer Centre criteria
- (2010) T. Gotoda et al. BRITISH JOURNAL OF SURGERY
- Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
- (2010) Mark P. Chao et al. CELL
- Modulation of Lymphocyte Regulation for Cancer Therapy: A Phase II Trial of Tremelimumab in Advanced Gastric and Esophageal Adenocarcinoma
- (2010) C. Ralph et al. CLINICAL CANCER RESEARCH
- Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer
- (2010) Wenjing Tian et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Gastric Cancer Working Group Report
- (2010) M. Sasako et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Effective Reduction of Gastric Cancer Risk With Regular Use of Nonsteroidal Anti-Inflammatory Drugs in Helicobacter Pylori–Infected Patients
- (2010) Chun-Ying Wu et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial
- (2010) Ilfet Songun et al. LANCET ONCOLOGY
- Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver
- (2010) L. Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
- (2010) M. A. Curran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mixed-type gastric cancer and its association with high-frequency CpG island hypermethylation
- (2010) Seog-Yun Park et al. VIRCHOWS ARCHIV
- Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis
- (2009) C C Abnet et al. BRITISH JOURNAL OF CANCER
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
- (2009) Ravindra Majeti et al. CELL
- LONG-TERM RESULTS OF GASTRIC CANCER SCREENING USING THE SERUM PEPSINOGEN TEST METHOD AMONG AN ASYMPTOMATIC MIDDLE-AGED JAPANESE POPULATION
- (2009) Kazumasa Miki et al. Digestive Endoscopy
- Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees
- (2009) Su Youn Nam et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Epstein-Barr virus associated gastric carcinoma: Epidemiological and clinicopathological features
- (2008) Suminori Akiba et al. CANCER SCIENCE
- Molecular dissection of the chromosome band 7q21 amplicon in gastroesophageal junction adenocarcinomas identifies cyclin-dependent kinase 6 at both genomic and protein expression levels
- (2008) H. van Dekken et al. GENES CHROMOSOMES & CANCER
- The Standardized Development Method of the Japanese Guidelines for Cancer Screening
- (2008) C. Hamashima et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial
- (2008) Kazutoshi Fukase et al. LANCET
- D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer
- (2008) Mitsuru Sasako et al. NEW ENGLAND JOURNAL OF MEDICINE
- Decreased death from gastric cancer by endoscopic screening: Association with a population-based cancer registry
- (2008) Osamu Hosokawa et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now